Cellular response of X-ray sensitive hamster mutant cell lines to gemcitabine, cisplatin and 5-fluorouracil

J Haveman1, N Castro Kreder, H M Rodermond

  • 1Department of Radiotherapy, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. j.haveman@amc.uva.nl

Oncology Reports
|June 18, 2004
PubMed

Insights

DNA repair pathways significantly influence cellular responses to chemotherapy. Homologous recombination is crucial for repairing cisplatin damage, while other pathways are not implicated in 5-FU or gemcitabine toxicity.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • DNA repair mechanisms are critical for maintaining genomic stability.
  • Understanding drug-induced DNA damage and cellular repair is vital for cancer therapy.
  • Chinese hamster cell lines offer a model for studying DNA repair deficiencies.

Purpose of the Study:

  • To investigate the role of specific DNA repair pathways in cellular sensitivity to cisplatin, 5-fluorouracil (5-FU), and gemcitabine.
  • To elucidate the mechanisms underlying chemoresistance and radiosensitization in DNA repair-deficient cells.

Main Methods:

  • Utilized five Chinese hamster cell lines with distinct DNA repair defects (single strand break repair, recombination mediated repair, double strand break repair, AT-like mutation).
  • Assessed cellular sensitivity to cisplatin, 5-FU, and gemcitabine.
  • Evaluated doubling time and X-irradiation sensitivity in mutant cell lines.

Main Results:

  • Mutant cell lines exhibited impaired growth and increased X-irradiation sensitivity.
  • Homologous recombination-associated DNA repair was confirmed as important for cisplatin-induced cytotoxicity.
  • Repair processes for radiation-induced damage were not implicated in 5-FU and gemcitabine toxicity.

Conclusions:

  • Homologous recombination is a key player in repairing cisplatin-induced DNA lesions.
  • 5-FU and gemcitabine toxicity do not appear to involve DNA repair pathways critical for radiation damage.
  • Differential roles of DNA repair pathways in chemoresistance highlight potential therapeutic strategies.